Parallel Advisors, LLC Crispr Therapeutics Ag Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Parallel Advisors, LLC holds 440 shares of CRSP stock, worth $21,067. This represents 0.0% of its overall portfolio holdings.

Number of Shares

440

Previous 839 47.56%

Holding current value

$21,067

Previous $45,000 55.56%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$44.62 - $62.75 $17,803 - $25,037	-399 Reduced 47.56%	440 $20,000
Q2 2024 Aug 08, 2024	BUY	$51.17 - $68.18 $4,912 - $6,545	96 Added 12.92%	839 $45,000
Q1 2024 May 06, 2024	BUY	$60.67 - $89.12 $23,721 - $34,845	391 Added 111.08%	743 $50,000
Q4 2023 Feb 09, 2024	BUY	$38.62 - $72.18 $5,368 - $10,033	139 Added 65.26%	352 $22,000
Q3 2023 May 20, 2024	BUY	$45.39 - $59.0 $907 - $1,180	20 Added 10.36%	213 $9,000
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $907 - $1,180	20 Added 10.36%	213 $9,000
Q1 2023 May 20, 2024	SELL	$41.0 - $56.12 $22,550 - $30,866	-550 Reduced 74.02%	193 $8,000
Q1 2023 Apr 25, 2023	SELL	$41.0 - $56.12 $1,927 - $2,637	-47 Reduced 19.58%	193 $8,000
Q4 2022 Feb 03, 2023	SELL	$39.19 - $65.67 $2,900 - $4,859	-74 Reduced 23.57%	240 $9,000
Q3 2022 Nov 10, 2022	SELL	$61.1 - $83.78 $183 - $251	-3 Reduced 0.95%	314 $21,000
Q2 2022 Aug 01, 2022	BUY	$43.23 - $73.83 $561 - $959	13 Added 4.28%	317 $19,000
Q1 2022 Apr 28, 2022	SELL	$53.19 - $79.24 $5,319 - $7,923	-100 Reduced 24.75%	304 $19,000
Q4 2021 Jan 20, 2022	BUY	$70.09 - $111.29 $5,186 - $8,235	74 Added 22.42%	404 $31,000
Q3 2021 Nov 02, 2021	SELL	$110.2 - $156.64 $11,350 - $16,133	-103 Reduced 23.79%	330 $37,000
Q2 2021 Aug 06, 2021	BUY	$100.84 - $161.89 $12,605 - $20,236	125 Added 40.58%	433 $70,000
Q1 2021 Apr 23, 2021	BUY	$110.72 - $210.04 $6,975 - $13,232	63 Added 25.71%	308 $38,000
Q4 2020 Feb 02, 2021	BUY	$79.67 - $173.23 $19,519 - $42,441	245 New	245 $38,000
Q2 2020 Jul 16, 2020	SELL	$38.5 - $76.05 $21,444 - $42,359	-557 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$33.68 - $62.53 $6,668 - $12,380	198 Added 55.15%	557 $23,000
Q2 2019 Aug 05, 2019	BUY	$35.45 - $48.2 $12,726 - $17,303	359 New	359 $17,000
Q3 2018 Nov 01, 2018	SELL	$44.35 - $65.71 $8,870 - $13,141	-200 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$42.62 - $73.59 $8,524 - $14,718	200 New	200 $11,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Crispr Therapeutics Ag Transaction History